September 2011/NutraSolutions -- PL Thomas, in association with Isocell S.A., Paris, recently announced the publication of the results of a new human clinical study using its exclusive dietary supplement ingredient, GliSODin®, in The International Journal of Sports Nutrition and Exercise Metabolism. GliSODin supplementation demonstrated positive effects on selected inflammatory markers in a 2,000 meter rowing ergometer test. The double-blinded study included 19 members of the Polish National Rowing Team who were participating in a training camp. Francois Vix, president of Isocell, noted: “The present trial confirms the findings of previous studies demonstrating the benefits of GliSODin for lessening inflammation resulting from strenuous exercise. The C-reactive protein level differences between GliSODin-protected subjects and the placebo group were quite remarkable, with CRP being an important measure of muscle inflammation.” Isocell, Paris, France, www.glisodin.org, PL Thomas, www.plthomas.com NS